Elevated Myeloid: Plasmacytoid Dendritic Cell Ratio Associates With Early Acute Cellular Rejection in Pediatric Small Bowel Transplantation

Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Transplantation (Impact Factor: 3.83). 01/2010; 89(1):55-60. DOI: 10.1097/TP.0b013e3181bc5d9e
Source: PubMed


Acute cellular rejection affects more than 60% of children after small bowel transplantation (SBTx). Dendritic cells (DCs) are potent antigen-presenting cells, modulate immune responses to gut microbes, and may serve as markers of rejection-prone small bowel transplantation (SBTx).
Myeloid CD11c DC (MDC), which may have inflammatory functions, and plasmacytoid CD123 DC (PDC), which may have tolerogenic potential, were measured by flow cytometric analysis, longitudinally (pretransplant, and at days 1 to 60, 61 to 200 posttransplant) in 23 children after SBTx. All children received cadaveric allografts with rabbit anti-human thymocyte globulin induction and steroid-free tacrolimus maintenance therapy. Rejectors were those children (n=16), who experienced biopsy-proven acute cellular rejection within 60 days of SBTx.
Of 69 maximum possible observations, 62 were available for analysis. Among rejectors, a significantly higher MDC:PDC ratio (P=0.004) was associated with numerically higher MDC counts and significantly lower PDC frequencies (P=0.017) during the 1- to 60-day time period, compared with nonrejectors. Logistic regression analysis, leave-one-out cross-validation, and receiver operating characteristic analysis revealed that MDC:PDC ratio more than or equal to 1.52 was associated with rejector status with sensitivity/specificity of 86/67% during the 1- to 60-day risk period for early SBTx rejection. Repeated measures analysis showed a significantly higher MDC:PDC ratio (P=0.043, F-test) among rejectors, compared with nonrejectors in cumulative data for pre-SBTx and 1- to 60-day time points. No correlation was seen between DC subsets and tacrolimus blood concentration at any time point.
We conclude that an elevated MDC:PDC ratio associates with early small bowel allograft rejection and may, therefore, identify at-risk recipients in the clinic.

27 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The paper presents the convergence phenomenon of the moment method, Floquet modal analysis, and spectral domain analysis of free standing arrays of dipoles. The ill-posed situation of a system of equations, Johansson's (1985) condition and the measurements of the transmission response are used to describe that phenomenon
    Radio Science Conference, 1996. NRSC '96., Thirteenth National; 04/1996
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: One of the most intensively studied holothurians, Holothuria scabra has been discussed in the literature since 1833. The species is important for several reasons: (1) it is abundant and widely distributed in shallow soft-bottom habitats throughout the Indo-Pacific; (2) it has a high value on the Asian markets, where it is mainly sold as beche-de-mer; and (3) it is the only tropical holothurian species that can currently be mass produced in hatcheries. Research on H. scabra continues but because of commercial exploitation, wild stocks are declining. This review compiles data from 14 these and 352 technical reports and scientific papers pertaining to the biology, ecology, aquaculture and fisheries of H. scabra. Although several references are likely to have been missed by our investigation, we present the most complete reference list to date, including obscure material published by local institutions and/or in foreign languages. Our main aim was to summarize and critically discuss the abundant literature on this species, making it more readily accessible to all those wishing to conduct fundamental research, or aquaculture and stock enhancement programmes, on H. scabra across its entire geographic range.
    Advances in Marine Biology 01/2001; 41(41):129-223. DOI:10.1016/S0065-2881(01)41003-0 · 3.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Immune monitoring is needed in small bowel transplantation (SBTx) because of a high incidence of rejection and graft loss, and life-threatening complications of high-dose prophylactic immunosuppression. Clinical tests relevant to SBTx include methods to detect antidonor human leukocyte antigen antibodies, among which those which use known purified human leukocyte antigen peptides as substrates correlate best with graft loss; enumerate peripheral lymphocyte subsets to determine the efficacy of lymphocyte-depleting antibodies; estimate general immune function based on ATP production by mitogen-stimulated T-helper cells. Research tests that show clinical utility in SBTx recipients include following markers. First, flow cytometric mixed leukocyte responses, which detect donor-induced proliferation of recipient T-cytotoxic cells by dilution of the intravital dye carboxyfluorescein succinimidyl ester, or donor-induced CD154 expression in recipient T-cytotoxic memory cells. Among such tests, CD154 T-cytotoxic memory cells achieve the highest known sensitivity and specificity of at least 90% for the detection of acute cellular rejection. Second, elevated fecal calprotectin, an early screening marker for intestinal inflammation, which can indicate the need for a SBTx biopsy, especially after ileostomy stoma closure. Third, single-nucleotide polymorphisms associated with inflammatory bowel diseases, for example, nucleotide-binding oligomerization protein, macrophage stimulating 1, and so on. These single-nucleotide polymorphisms may be used to select the rejection-prone SBTx recipient for more potent immunosuppression, if additional studies confirm their associations with outcomes. The final approach to monitor the SBTx recipient will likely involve using the method(s) with the best sensitivity and specificity for detecting acute cellular rejection or graft loss during time periods when such events are most likely.
    Current opinion in organ transplantation 06/2010; 15(3):349-56. DOI:10.1097/MOT.0b013e328339489c · 2.88 Impact Factor
Show more